Table 4 Luteinizing hormone levels in relation to genotypes in the PCOS group. Data are presented as the geometric means (95%CI).

From: Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes

Nearest gene

SNP

Genotype

n

Luteinizing hormone

(IU/L)

P

FSHB

rs11031006

GG

453

9.54 (2.20, 2.32)

1.96 × 10−3

  

AA + AG

67

12.95 (2.37, 2.70)

 

FSHR

rs2268361

AA

124

9.6 (2.13, 2.37)

0.41

  

GG + GA

396

10.0 (2.24, 2.38)

 

LHCGR

rs10176989

AA

373

9.80 (2.21, 2.35)

0.45

  

CC + CA

147

10.2 (2.22, 2.44)

 

TOX3

rs11075466

AA

200

9.44 (2.15, 2.34)

0.20

  

GG + GA

320

10.2 (2.25, 2.40)

 

RAB5B

rs705704

GG

290

9.80 (2.21, 2.36)

0.73

  

AA + AG

230

10.1 (2.22, 2.40)

 

KHDRBS3

rs10505648

AA

458

9.74 (2.21, 2.34)

0.051

  

GG + GA

62

11.4 (2.28, 2.62)

 

YAP1

rs1894116

AA

333

9.92 (2.22, 2.37)

0.80

  

GG + GA

187

9.94 (2.20, 2.39)

 

THADA

rs13429458

CC

319

10.4 (2.25, 2.37)

0.12

  

AA + AC

196

9.2 (1.83, 2.39)

 

DENDD1A

rs2479106

AA

261

9.5 (2.16, 2.33)

0.096

  

GG + GA

259

10.3 (2.26, 2.43)

 

INSR

rs2059807

AA

252

10.5 (2.25, 2.42)

0.16

  

GG + GA

268

9.41 (2.17, 2.34)

 

C9orf3

rs4385527

GG

333

10.3 (2.25, 2.40)

0.17

  

AA + AG

187

9.29 (2.14, 2.34)

 

SUMO1P1

rs6013809

CC

193

9.34 (2.24, 2.34)

0.27

  

AA + AC

321

9.70 (2.19, 2.34)

 
  1. All results were adjusted for age and body mass index.
  2. CI, confidence interval; PCOS, polycystic ovary syndrome; SNP, single nucleotide polymorphism.